Beyond modest lipid improvements, GLP-1 receptor agonists have demonstrated substantial cardiovascular benefits in large-scale outcome trials, establishing them as important cardioprotective agents for appropriate patients
Department of Health and Human Services, 2025, www.nia.nih.gov/health/menopause/what-menopause.
Lancet 402 , 529544 (2023)
Randomized, controlled, multicentered, double-blind investigation of injectable poly-L-lactic acid for improving skin quality
Insulin users must plan exercise carefully, often reducing their insulin dose before planned physical activity to prevent exercise-induced hypoglycemia
Multiple factors converged: FDA approval for weight loss, celebrity endorsements, television coverage, and growing clinical evidence fueled demand that manufacturers could not immediately match